Cellular Responses to Extracellular Vesicles As Potential Markers of Colorectal Cancer Progression

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Dec 9

PMID 38069076

Authors

Sonia Guarnerio

Robert Tempest

Rawan Maani

Stuart Hunt

Laura M Cole

Christine L Le Maitre

Keith Chapple

Nicholas Peake

Affiliations

Soon will be listed here.

Abstract

The development of novel screening tests aims to support early asymptomatic diagnosis and subtyping patients according to similar traits in the heterogeneous cancer cohort. Extracellular vesicles (EVs) are promising candidates for the detection of disease markers from bodily fluids, but limitations in the standardisation of isolation methods and the intrinsic EV heterogeneity obtained from liquid biopsies are currently obstacles to clinical adoption. Here, cellular responses to cancer EVs were initially explored as potential complementary biomarkers for stage separation using colorectal cancer (CRC) SW480 and SW620 cell line models. A pilot study on a small cohort of CRC patients and controls was then developed by performing a multivariate analysis of cellular responses to plasma-derived EVs. Several cell activities and markers involved in tumour microenvironment pathways were influenced by the treatment of cell line EVs in a stage-dependent manner. The multivariate analysis combining plasma EV markers and cellular responses to plasma EVs was able to separate patients according to disease stage. This preliminary study offers the potential of considering cellular responses to EVs in combination with EV biomarkers in the development of screening methods.

References

Lone S, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S . Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Mol Cancer. 2022; 21(1):79. PMC: 8932066. DOI: 10.1186/s12943-022-01543-7. View

Li C, Wang J, Kong J, Tang J, Wu Y, Xu E . GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget. 2015; 7(1):860-72. PMC: 4808038. DOI: 10.18632/oncotarget.6205. View

Gong Y, Scott E, Lu R, Xu Y, Oh W, Yu Q . TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression. PLoS One. 2013; 8(10):e77366. PMC: 3797040. DOI: 10.1371/journal.pone.0077366. View

Pang H, Liu L, Sun X, Xi W, Bao Y, Wu L . Exosomes derived from colon cancer cells and plasma of colon cancer patients promote migration of SW480 cells through Akt/mTOR pathway. Pathol Res Pract. 2021; 222:153454. DOI: 10.1016/j.prp.2021.153454. View

Zhang X, Zhang Y, Qiu X, Cai J, Yang Z, Song F . Extracellular Vesicles Derived from Lung Cancer Cells Induce Transformation of Normal Fibroblasts into Lung Cancer-Associated Fibroblasts and Promote Metastasis of Lung Cancer by Delivering lncRNA HOTAIR. Stem Cells Int. 2022; 2022:3805013. PMC: 9578906. DOI: 10.1155/2022/3805013. View

Giusti I, Di Francesco M, Poppa G, Esposito L, DAscenzo S, Dolo V . Tumor-Derived Extracellular Vesicles Activate Normal Human Fibroblasts to a Cancer-Associated Fibroblast-Like Phenotype, Sustaining a Pro-Tumorigenic Microenvironment. Front Oncol. 2022; 12:839880. PMC: 8905682. DOI: 10.3389/fonc.2022.839880. View

Slater C, Mare J, Edkins A . analysis of putative cancer stem cell populations and chemosensitivity in the SW480 and SW620 colon cancer metastasis model. Oncol Lett. 2018; 15(6):8516-8526. PMC: 5950524. DOI: 10.3892/ol.2018.8431. View

Abdouh M, Floris M, Gao Z, Arena V, Arena M, Arena G . Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells. J Exp Clin Cancer Res. 2019; 38(1):257. PMC: 6567673. DOI: 10.1186/s13046-019-1248-2. View

Dong L, Zieren R, Horie K, Kim C, Mallick E, Jing Y . Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium. J Extracell Vesicles. 2021; 10(2):e12044. PMC: 7810129. DOI: 10.1002/jev2.12044. View

10.

Zhou B, Huang Y, Feng Q, Zhu H, Xu Z, Chen L . TRIM16 promotes aerobic glycolysis and pancreatic cancer metastasis by modulating the NIK-SIX1 axis in a ligase-independent manner. Am J Cancer Res. 2022; 12(11):5205-5225. PMC: 9729885. View

11.

Sepulveda A, Hamilton S, Allegra C, Grody W, Cushman-Vokoun A, Funkhouser W . Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol. 2017; 35(13):1453-1486. DOI: 10.1200/JCO.2016.71.9807. View

12.

Scavo M, Rizzi F, Depalo N, Fanizza E, Ingrosso C, Curri M . A Possible Role of FZD10 Delivering Exosomes Derived from Colon Cancers Cell Lines in Inducing Activation of Epithelial-Mesenchymal Transition in Normal Colon Epithelial Cell Line. Int J Mol Sci. 2020; 21(18). PMC: 7555665. DOI: 10.3390/ijms21186705. View

13.

Suwakulsiri W, Rai A, Xu R, Chen M, Greening D, Simpson R . Proteomic profiling reveals key cancer progression modulators in shed microvesicles released from isogenic human primary and metastatic colorectal cancer cell lines. Biochim Biophys Acta Proteins Proteom. 2018; 1867(12):140171. DOI: 10.1016/j.bbapap.2018.11.008. View

14.

Kotelevets L, Chastre E . Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications. Cancers (Basel). 2023; 15(4). PMC: 9953945. DOI: 10.3390/cancers15041107. View

15.

Rao V, Gu Q, Tzschentke S, Lin K, Ganig N, Thepkaysone M . Extravesicular TIMP-1 is a non-invasive independent prognostic marker and potential therapeutic target in colorectal liver metastases. Oncogene. 2022; 41(12):1809-1820. PMC: 8933275. DOI: 10.1038/s41388-022-02218-9. View

16.

Mao X, Tey S, Yeung C, Kwong E, Fung Y, Chung C . Nidogen 1-Enriched Extracellular Vesicles Facilitate Extrahepatic Metastasis of Liver Cancer by Activating Pulmonary Fibroblasts to Secrete Tumor Necrosis Factor Receptor 1. Adv Sci (Weinh). 2020; 7(21):2002157. PMC: 7640351. DOI: 10.1002/advs.202002157. View

17.

Li S, Ma Y, Zheng P, Zhang P . GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. J Exp Clin Cancer Res. 2018; 37(1):80. PMC: 5894198. DOI: 10.1186/s13046-018-0744-0. View

18.

Kamel F, Eltarhoni K, Nisar P, Soloviev M . Colorectal Cancer Diagnosis: The Obstacles We Face in Determining a Non-Invasive Test and Current Advances in Biomarker Detection. Cancers (Basel). 2022; 14(8). PMC: 9029324. DOI: 10.3390/cancers14081889. View

19.

Hennessey J . The emergence of levothyroxine as a treatment for hypothyroidism. Endocrine. 2016; 55(1):6-18. DOI: 10.1007/s12020-016-1199-8. View

20.

Hagey D, Ojansivu M, Bostancioglu B, Saher O, Bost J, Gustafsson M . The cellular response to extracellular vesicles is dependent on their cell source and dose. Sci Adv. 2023; 9(35):eadh1168. PMC: 11629882. DOI: 10.1126/sciadv.adh1168. View